Asiatic sweetleaf
Symplocos paniculata
Symplocos paniculata is a plant species utilized within certain traditional medicinal practices. It has been historically applied for the treatment of amebiasis and ophthalmia. Scientific research has primarily focused on the plant's physiological processes, such as oil biosynthesis in the mesocarp and seeds, sugar metabolism during fruit maturation, and the mechanisms of seed dormancy. There is currently no clinical evidence regarding its medicinal efficacy in humans. No major safety issues or notable drug interactions have been recorded in the available data.
- Traditionally for
- amebiasis · ophthalmia
- Traditions
- traditional
- Best evidence
- D
- Cautions
- —
Informational only. Traditional use does not mean proven effectiveness. Evidence and safety vary — check the cited sources.
Traditional use
- amebiasis
- ophthalmia
What the science says
- The study found that oil biosynthesis begins earlier in the mesocarp than in the seeds of Symplocos paniculata, with different fatty acid compositions and gene expression patterns observed between the two tissues.
- This study found that treating Symplocos paniculata seeds with specific scarification, GA3 soaking, and stratification methods can significantly increase germination rates while elucidating underlying physiological changes.
- The study found that sugar metabolism influences oil synthesis in Symplocos paniculata fruits differently during early development and maturation stages.
- The study found that Symplocos paniculata seeds exhibit physiological dormancy due to endogenous inhibitors and mechanical restriction by the lignified endocarp.
Frequently asked questions
What is Asiatic sweetleaf?
Asiatic sweetleaf (Symplocos paniculata) is a plant documented in FolkKB's traditional-medicine reference, drawn from sourced literature and cross-checked against the evidence.
What is Asiatic sweetleaf traditionally used for?
Traditional sources record Asiatic sweetleaf for: amebiasis, ophthalmia. This reflects traditional use, not a proven medical treatment.
Which traditions use Asiatic sweetleaf?
Asiatic sweetleaf appears in these traditions in our sources: traditional.
What does the scientific evidence say about Asiatic sweetleaf?
4 sourced findings are recorded for Asiatic sweetleaf; the strongest carries evidence grade D. For example: The study found that oil biosynthesis begins earlier in the mesocarp than in the seeds of Symplocos paniculata, with different fatty acid compositions and gene expression patterns observed between the two tissues.
How strong is the evidence for Asiatic sweetleaf?
The strongest finding for Asiatic sweetleaf carries evidence grade D — preliminary or traditional. Grades run A (strongest) to D (preliminary or traditional).
Is Asiatic sweetleaf safe? What are the side effects?
No major safety issues are recorded for Asiatic sweetleaf in our sources, but the data may be incomplete. Consult a qualified professional before use.
Does Asiatic sweetleaf interact with medications?
No drug interactions are recorded for Asiatic sweetleaf in our sources. This does not rule them out — check with a pharmacist.
Is Asiatic sweetleaf a proven treatment?
No. FolkKB is informational only. Traditional use and early findings are not proof of efficacy or safety — consult a qualified professional and never self-treat.
Sources
- T3 Dr. Duke's Ethnobotanical Database public domain (USDA ARS — attribute Dr. Duke's)
- T2 Characterization and mechanism of seed dormancy in Symplocos paniculata. literature abstract metadata
- T2 Methodological and Physiological Study during Seed Dormancy Release of Symplocos paniculata. literature abstract metadata
- T2 Comparative analysis of transcriptome in oil biosynthesis between seeds and non-seed tissues of Symplocos paniculata fruit. literature abstract metadata
- T2 Regulatory mechanism of carbohydrate metabolism pathways on oil biosynthesis of oil plant Symplocos paniculata. literature abstract metadata